TOKYO (JAPAN) – AstraZeneca becomes the second drug maker to apply for approval in Japan for its COVID-19 vaccine, after Pfizer Inc.
The Japanese government in December signed a contract to procure 120 million doses of AstraZeneca vaccine, enough for 60 million people.
